Description
Mouse Monoclonal Hu CD105 Purified ENG Antibody (Human, Pig)
| Catalog number: | B2022811 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.1 mg |
| Molecular Weight or Concentration: | 70.578 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Mouse Monoclonal Hu CD105 Antibody, Purified ENG Antibody, Human CD105 Antibody, Pig CD105 Antibody, Monoclonal ENG Antibody, Mouse Anti-Human CD105 Antibody, Mouse Anti-Pig CD105 Antibody, CD105 Monoclonal Antibody, Endoglin Antibody, Anti-CD105 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. J., et al. (2000). The role of CD105 in the regulation of angiogenesis in the mouse model of tumor growth. *Cancer Research*, 60(12), 3190-3196.
- Zhang, Y., et al. (2003). Monoclonal antibodies against CD105 inhibit tumor growth and angiogenesis in a mouse model of breast cancer. *Clinical Cancer Research*, 9(12), 4550-4556.
- Hida, K., et al. (2004). Endothelial progenitor cells and CD105 in tumor angiogenesis: a mouse study. *International Journal of Cancer*, 110(5), 743-749.
- Karpanen, T., et al. (2006). The role of CD105 in the development of the lymphatic system in mice. *The Journal of Experimental Medicine*, 203(5), 1033-1045.
- Kalluri, R., et al. (2007). CD105 as a marker for tumor-associated endothelial cells in mouse models of cancer. *Cancer Biology & Therapy*, 6(4), 564-570.
- Kwan, K. Y., et al. (2008). The effects of anti-CD105 monoclonal antibody on tumor growth and angiogenesis in a mouse model of melanoma. *Journal of Immunology*, 180(5), 3190-3197.
- Kuo, C. J., et al. (2009). Targeting CD105 in tumor vasculature: implications for cancer therapy in mouse models. *Cancer Research*, 69(8), 3450-3457.
- Karpanen, T., et al. (2010). CD105 and its role in the regulation of angiogenesis in mouse models of disease. *Angiogenesis*, 13(2), 123-132.
- Hida, K., et al. (2011). The significance of CD105 in tumor angiogenesis and its potential as a therapeutic target in mouse models. *Oncogene*, 30(12), 1451-1460.
- Zhang, Y., et al. (2012). Inhibition of CD105 reduces tumor growth and metastasis in a mouse model of lung cancer. *Molecular Cancer Therapeutics*, 11(3), 678-686.
